According to Foresight News, AminoChain announced the completion of a $5 million seed round of financing, led by a16z, which is the first decentralized science project invested by a16z.

AminoChain is building an L2 blockchain protocol that connects corporate medical institutions. The first application built on AminoChain is a biological sample market that allows researchers to query and license samples through a biological sample library network. Patients can track their sample usage, learn from new insights generated from samples, and make money when selling these samples.